CS Paper Radar

Quantitative Evidence Mining for Plausibility-Aware Biomedical AI: A Narrative Review and Conceptual Framework

Negin Sadat Babaiha, Stefan Geissler, Marie-Christine Simon, Martin Hofmann-Apitius, Marc Jacobs

cs.CL ·submitted 2026-08-31 07:48 UTC · v2

Abstract

Biomedical artificial intelligence is moving from literature retrieval toward evidence synthesis for knowledge graphs, clinical decision support, and computational models. Yet most information-extraction systems still represent findings as simple relations, discarding the quantitative and contextual detail needed for interpretation and reuse. A claim that one entity affects another is insufficient when the magnitude, unit, population, comparator, experimental conditions, uncertainty, and provenance are missing. We define quantitative evidence mining as a framework for transforming biomedical findings into structured, context-rich, and auditable evidence units. We define the core elements of an evidence unit: the claim; measured entity and property; value, unit, or scale; comparator; population; biological or clinical conditions; temporal context; uncertainty; provenance; validation results; and expert-review status. We propose an eight-stage reference architecture spanning corpus selection, entity recognition, quantity extraction, context linking, normalization, evidence-unit assembly, multidimensional plausibility assessment, and export and governance. A central principle is that plausibility should not be collapsed into a single truth label; statistical, biological, methodological, contextual, and provenance-based support should remain explicit. The framework links information extraction to evidence synthesis and computational reuse, with applications in clinical-trial analysis, biomarker research, pharmacovigilance, knowledge-graph construction, and mechanistic modelling. It is a research agenda rather than a validated end-to-end system. Progress will require annotated multimodal benchmarks, rigorous component- and workflow-level evaluation, prospective testing, transparent provenance, and sustained expert oversight.

Closest papers

Nearest neighbours by meaning across the whole index.

A Semantic Model of Genetic Evidence: A Step Toward Bridging the Basic-Science-Clinic Gap

cs.DB cs.AIq-bio.GN ·2026-09-03 ·Michael Bouzinier, Dmitry Etin
benchmarkpositioncode/data similarity 0.75
Abstract · 16 pages; supplementary material (32 pages) included in this submission. Schema, annotations, and code: https://github.com/ForomePlatform/ge…

Scientific and clinical decision-making depends on evidence from the primary literature, but existing standards for representing that evidence (FHIR Evidence, ECO, SEPIO, and the GA4GH Genomic Knowledge Standards) are oriented toward clinical-trial workflows, evidence codes, or single-variant assertions, and do not capture the fine-grained, domain-specific structure of claims in basic and pre-clinical research. We introduce a semantic model for scientific evidence with three core classes, specialize it for genetics, align it structurally to FHIR Evidence with a SEPIO-anchored credibility decomposition, and attach a compact dimensional vocabulary whose conditional-activation rules are validated by a SHACL schema for the implemented constraints. Using clinical variant interpretation as the driving use case, we evaluate the model through a human-AI annotation pilot over six genetics papers, yielding 28 evidence items and 95 source-anchored assertions, with a workflow that keeps curator-authored reference annotations distinct from AI-drafted annotations. Treating the pilot as a feasibility study rather than a benchmark, we argue that the model is a useful increment toward trustworthy, AI-ready infrastructure for variant interpretation: a reference data model and validation schema for representing genetic evidence.

0.31

CLEAR: Cross-Source Evidence Adjudication for Large Language Models in Medicine

cs.AI cs.CL ·2026-09-14 ·Shuai Wang, Yize Zhao, Qingyu Chen
similarity 0.69
Abstract · 31 pages

Medical knowledge evolves continuously, whereas the parametric knowledge encoded in large language models (LLMs) is fixed at training time. External retrieval, including retrieval-augmented generation (RAG), can provide access to newly available evidence, but retrieved information may be irrelevant, incomplete, or conflicting. As a result, external retrieval can in turn degrade the factual accuracy and evidence grounding of LLM outputs. To address this challenge, we propose \textbf{CLEAR}, an agentic framework for cross-source evidence adjudication in LLMs in medicine. CLEAR independently generates candidate answers from three complementary pathways---parametric knowledge, locally curated corpora, and dynamically retrieved evidence---reflecting three common sources of information available to LLMs. An aggregation verifier jointly evaluates the candidates, supporting evidence, provenance, and source-quality information to identify agreement and conflict across sources. An adjudication module then determines whether the current conclusion should be preserved or revised through complementary override-guard and challenge-audit mechanisms, while unresolved conflicts trigger targeted follow-up search and re-adjudication.

0.11

Proof-Grounded Patient-Specific Clinical Explanations from Knowledge-Graph Reasoning

cs.AI ·2026-10-05 ·Surajit Das
similarity 0.68
Abstract

Clinical decision-support outputs can lack an au- ditable link between patient observations, encoded knowledge, conclusions, and recommendations. We present the CKG Clinical Explanation Engine, a downstream layer for a frozen, training-free clinical knowledge-graph reasoner that converts patient inference states and disease knowledge into typed facts, explicit rule-application traces, provenance-linked conclusions, and policy-licensed recommendations. The design separates measurement availability, representation completeness, and disease-specific activation; consequently, observed zero-activation evience is not treated as missing and partial representation is distinct from unobserved evidence. Optional language generation is restricted to symbolically licensed content. Across five usable workbooks (6,720 patients; 20,160 patient-disease traces; 1,021,440 feature-evidence rows), IG-range validity and knowledge provenance were 100%, numerical cross-sheet fidelity was 100% (120,960/120,960), and exported logical/report trace completeness was 100% (20,160/20,160). Availability representation consistency was 99.7028% (1,018,404/1,021,440); all 3,036 disagreements were confined to three systematic feature-cohort patterns. The corpus contained 86,783 observed zero-activation and 139,949 observed partially represented instances. A separate seeded 25-patient end-to-end audit completed without execution failure and passed all pre-specified trace, licensing, provenance, and state-consistency checks. These results establish structural and implementation auditability, not clinical correctness or utility.

0.08

Generating Biomedical Fact-Checking Reports with RL-Enhanced Agentic Search

cs.AI ·2026-08-24 ·Jiongxiao Wang, Dingli Ma, Chaoqun Ni
code/data similarity 0.67
Abstract

Automated fact-checking is essential for ensuring the reliability of public health information, yet the biomedical domain poses unique challenges. Validating biomedical claims requires rigorous interpretation of scientific literature, assessment of retrieved evidence, and comprehensive justification toward the conclusion. Although Large Language Models (LLMs) enhanced by Retrieval-Augmented Generation (RAG) and agentic search perform automated fact-checking in a retrieve-then-verify paradigm, current methods still output isolated prediction labels, lacking explanatory depth and offers limited utility for human understanding. To bridge this gap, we introduce an LLM-based agent named BioCheck Agent that generates structured biomedical fact-checking reports with agentic search. Rather than merely outputting supported or refuted labels, our agent synthesizes final conclusions with retrieved evidence and rigorous analysis. To ensure domain-specific accuracy, BioCheck Agent exclusively searches high-quality scientific literature in PubMed, utilizing advanced Boolean search operators. Recognizing that direct prompting often results in hallucinations and low-quality reports, especially for lightweight open-source models, we further propose the Evidence-Grounded Group Relative Policy Optimization (EG-GRPO) to perform reinforcement learning on BioCheck Agent with a task-specific reward that incentivizes advanced search behavior and high-quality evidence retrieval while penalizing hallucinations. Our experimental results show that compared to the base model Qwen3.5-4B, BioCheck Agent with EG-GRPO improves label prediction accuracy on SciFact by 9.95%. Furthermore, it achieves a 3.7% higher evidence quality score and a 19.63% lower evidence hallucination rate, demonstrating its ability to generate biomedical fact-checking reports with improved accuracy and quality.

0.32

MedCaseAgent: From Multimodal Clinical Evidence to Rare Disease Case Reports

cs.AI ·2026-10-23 ·Hongkang Chu, Yifan Shen, Tianjiao Yu, Zhuoqing Zhong, Jianguo Cao +2 more
code/data similarity 0.67
Abstract

Although Large Language Models (LLMs) have demonstrated potential in clinical documentation, generating the rigorous, evidence-based reasoning required for unprecedented, atypical, and rare disease case reports remains a significant challenge. We present MedCaseAgent, an end-to-end agentic reasoning paradigm that bridges this gap by synthesizing publication-quality reports from unstructured clinical notes. MedCaseAgent leverages a hierarchical structure, integrating patient-level data mining with iterative, tool-integrated reasoning. By dynamically querying medical literature and knowledge bases, the agent maintains high clinical fidelity and assesses case novelty. The framework is inherently modular, supporting various backbone LLMs in a plug-and-play fashion. To facilitate this research, we release MedCase-150K, a large-scale multimodal clinical case-report corpus, and MedCase-Bench, a robust temporally held-out evaluation suite. We also introduce an open-source model post-trained from Qwen3.5-9B and optimized specifically for this task. Under both LLM-judged and rule-based evaluation, MedCaseAgent outperforms existing general-purpose and specialized medical LLMs and agents. Blinded expert reviews and ablations further support the system's clinical relevance and evidence grounding.

0.25

Where Does Retrieval-Based Open-Ended Evaluation Fail? Automatic Taxonomy Induction from Long-Form Medical Answer Factuality Verification

cs.CL cs.IR ·2026-09-24 ·Heyuan Huang, Jirui Dai, Alexandra DeLucia, Sonal Joshi, Mahsa Yarmohammadi +3 more
top venue similarity 0.67
Abstract · All experiments were done before May 2026 (also all corpus knowledge cutoff date). Accepted as an Oral paper (Best Paper Finalist) at NeurIP…

Retrieval-based factuality evaluation, where LLM-generated claims are verified against evidence from authoritative medical corpora, has become the dominant paradigm for scalable hallucination detection in high-stakes clinical settings. Despite the urgency of reliable and transparent medical fact verification, most systems measure performance with aggregate metrics like F1, which obscure where and why failures occur. Existing RAG diagnostics require gold answers or annotated gold evidence, neither of which exists in this regime. We introduce two comprehensive taxonomies, grounded in a case study on the open-ended MedExpert dataset and 3 closed-ended datasets, decomposing failures into retrieval-stage errors along five quality dimensions, and verifier-reasoning errors into six consecutive steps. We adapt an automatic pattern induction pipeline using LLM-as-Judge to label evidence quality and classify verifier reasoning errors at scale, and then stress-test our findings across 4 retrieval methods and 6 frontier verifier models. Our analysis reveals that scaling model size, adding reasoning effort, expanding to authoritative web sources, and applying medical fine-tuning do not resolve these failure modes, demonstrating that they represent fundamental limitations of the retrieve-then-verify paradigm in open-ended medical settings rather than artifacts of outdated systems. We release our code and data at https://anonymous.4open.science/r/Medical_RAG_eval-4AB5 for the full reproducibility of our results.

0.36

Cite What You Explore: Budget-Aware LLM Reasoning over Medical KGs with Verifiable Evidence

cs.LG ·2026-10-06 ·Chen Chen, Dongjie Wang, Mei Liu, Zijun Yao
top venuebenchmarkcode/data similarity 0.66
Abstract · Accepted to NeurIPS 2026. This revision corrects cohort statistics and efficiency reporting, removes incorrectly reported per-disease standa…

Post-discharge risk prediction from electronic health records (EHRs) is difficult because many dependencies that link discharge-time observations to downstream complications, such as comorbidity cascades and drug-disease interactions, are absent from the record. External medical knowledge graphs (KGs) can supply these missing dependencies, but tracing them in a clinical setting demands three properties. KG exploration must remain cost-bounded, retrieved evidence must be differentiated by source quality, and the resulting rationale must be citable for review. Large language models (LLMs) can plan and verify over structured evidence, making them natural candidates for KG reasoning, but existing LLM-based methods do not satisfy these three properties jointly. In this paper, we propose BAR, a Budget-Aware LLM Reasoning framework over medical KGs with three contributions. First, BAR refines the raw KG into disease-specific evidence graphs whose edges carry support scores and provenance records, turning the KG into a quality-annotated reasoning space rather than a static feature source. Second, an LLM reasons over this graph through a plan-navigate-verify loop that decomposes the question into steps, retrieves evidence under a patient-specific budget, and revises when verification fails. Third, a reasoning policy is trained with a reward that compares predictions with and without acquired evidence, combined with acquisition cost and citation-integrity terms. Across 8 diseases and 3 prediction horizons on MIMIC-III and MIMIC-IV, BAR achieves higher performance and citation precision than strong baselines while using fewer LLM tokens. Its gain over EHR-only prediction grows at longer horizons, and its advantage carries over to an external benchmark.

0.36

From archive to resource: bringing legacy data back to life at scale with large language models

cs.IR ·2026-10-23 ·C. H. Vieira-Vieira, I. Schneider Chernov, A. Serra, M. Correa Marrero, P. L. Bhavani Mohan +3 more
benchmark similarity 0.65
Abstract

Pharmaceutical companies maintain vast archives of legacy preclinical study reports that contain study-context details, such as fasting, anesthesia, and laboratory instrumentation, that are rarely captured in structured data formats, yet they can correlate with clinical pathology parameters values and limit the reuse of historical data. This work demonstrates practical, scalable solutions to recover such descriptors from heterogeneous report texts using large language model (LLM)-based extraction pipelines developed independently by two industry teams. The pipelines identify and normalize metadata fields and return verbatim evidence with page and section reference, hasting human verification and iterative refinement. Evaluation of over 400 documents against expert-curated reference values showed high agreement across a broad set of metadata fields. Performance was strongest for consistently reported items and lower for descriptors subject to linguistic or report structure variability. Extraction time has shrunk from 25 minutes in the manual benchmark to 1.6 minutes. As a concrete biological demonstration, we show that fasting status extracted from report text was associated with species- and analyte-specific shifts in clinical chemistry parameters, illustrating how recovered metadata can improve selection of historical controls. Key strengths of the approach are scalability, traceability, and the ability to recover information missing from current industry standards. Main limitations are dependence on source-report quality and initial expert effort to define and refine schemas. These results establish how LLMs can convert heterogeneous, unstructured legacy reports into evidence-grounded, reusable and structured metadata, leading to better experimental comparability, and thus enabling reliable data pooling or informed virtual control selection.

0.28